A histopathological study of pulmonary hypertension in connective tissue disease

Nobuhito Sasaki1, Akihisa Kamataki, Takashi Sawai

  • 1Department of Pathology, Iwate Medical University, Iwate, Japan.

Insights

Connective tissue diseases (CTD) can cause pulmonary hypertension (PH). Histological analysis reveals distinct pathological features of PH specific to systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCTD).

Area of Science:

  • Pulmonary Medicine
  • Rheumatology
  • Pathology

Background:

  • Connective tissue diseases (CTD), including systemic sclerosis (SSc), systemic lupus erythematosus (SLE), and mixed connective tissue disease (MCTD), are known to cause pulmonary hypertension (PH).
  • Current classifications group all CTD-associated PH (CTD-PH) into a single category.
  • However, distinct pathological findings exist for PH within each specific CTD.

Purpose of the Study:

  • To review and describe the specific pathological features of pulmonary hypertension (PH) associated with different connective tissue diseases (CTD).
  • To highlight the histological differences in PH lesions among SSc, SLE, and MCTD.

Main Methods:

  • Review of existing literature on the pathology of pulmonary hypertension in CTD.
  • Comparative analysis of histological findings in PH associated with SLE, SSc, and MCTD.

Main Results:

  • Pulmonary hypertension in SLE often shows mild fibrosis, resembling primary pulmonary hypertension.
  • Systemic sclerosis (SSc)-associated PH frequently involves significant fibrosis.
  • Mixed connective tissue disease (MCTD)-associated PH shares similarities with SSc, characterized by fibrous intimal thickening in arteries and arterioles.

Conclusions:

  • Pulmonary hypertension exhibits unique pathological characteristics depending on the underlying connective tissue disease.
  • Histological examination is crucial for differentiating PH subtypes within CTD.
  • Recognizing these specific lesions can inform diagnosis and potentially guide treatment strategies for CTD-PH.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...